Literature DB >> 23244099

Esophageal cancer mortality during 2004-2009 in Yanting County, China.

Qing-Kun Song1, Jun Li, Hai-Dong Jiang, Yu-Ming He, Xiao-Qiao Zhou, Cheng-Yu Huang.   

Abstract

OBJECTIVE: Yanting County is a high risk area for esophageal cancer (EC) in China. The purpose of this study was to describe the mortality and mortality change of EC from 2004 to 2009 in Yanting County.
METHODS: EC mortality data from 2004 to 2009 obtained from the Cancer Registry in Yanting were analyzed. Annual percentage changes (APC) were calculated to assess the trends in EC mortality. Age-standardized mortality was calculated based on world standard population of 2000.
RESULTS: The average EC mortality was 54.7/105 in males and 31.6/105 in females over the 6 years. A decline in EC mortality with time was observed in both genders, with a rate of -8.70% per year (95% CI: -13.23%~-3.93%) in females and -4.11% per year (95%CI: -11.16%~3.50%) in males.
CONCLUSION: EC mortality decreased over the six years in both genders, although it remained high in the Yanting area. There is still a need to carry out studies of risk factors for improved cancer prevention and further reduction in the disease burden.

Entities:  

Mesh:

Year:  2012        PMID: 23244099     DOI: 10.7314/apjcp.2012.13.10.5003

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  2 in total

1.  Population and single‑cell transcriptome analyses reveal diverse transcriptional changes associated with radioresistance in esophageal squamous cell carcinoma.

Authors:  Hongjin Wu; Juehua Yu; Deshengyue Kong; Yu Xu; Zunyue Zhang; Jing Shui; Ziwei Li; Huayou Luo; Kunhua Wang
Journal:  Int J Oncol       Date:  2019-10-14       Impact factor: 5.650

2.  Elevated p53 expression levels correlate with tumor progression and poor prognosis in patients exhibiting esophageal squamous cell carcinoma.

Authors:  Kate Huang; Lin Chen; Jiliang Zhang; Zhi Wu; Linhua Lan; Lu Wang; Bin Lu; Yongzhang Liu
Journal:  Oncol Lett       Date:  2014-07-11       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.